Puma Biotechnology (PBYI) Income towards Parent Company (2017 - 2025)
Historic Income towards Parent Company for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $8.8 million.
- Puma Biotechnology's Income towards Parent Company fell 5647.0% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.9 million, marking a year-over-year increase of 2866.49%. This contributed to the annual value of $23.2 million for FY2024, which is 746.61% up from last year.
- According to the latest figures from Q3 2025, Puma Biotechnology's Income towards Parent Company is $8.8 million, which was down 5647.0% from $5.9 million recorded in Q2 2025.
- Puma Biotechnology's Income towards Parent Company's 5-year high stood at $20.3 million during Q3 2024, with a 5-year trough of -$44.7 million in Q3 2021.
- For the 5-year period, Puma Biotechnology's Income towards Parent Company averaged around $1.8 million, with its median value being $3.0 million (2025).
- Per our database at Business Quant, Puma Biotechnology's Income towards Parent Company surged by 171000.0% in 2023 and then tumbled by 44368.31% in 2024.
- Quarter analysis of 5 years shows Puma Biotechnology's Income towards Parent Company stood at $4.2 million in 2021, then crashed by 232.72% to -$5.6 million in 2022, then skyrocketed by 318.84% to $12.3 million in 2023, then decreased by 0.31% to $12.2 million in 2024, then fell by 27.69% to $8.8 million in 2025.
- Its Income towards Parent Company was $8.8 million in Q3 2025, compared to $5.9 million in Q2 2025 and $3.0 million in Q1 2025.